Fantastic reading, as expected.
I have confidence in their approach below - which history show is exactly what they did for PhII for Trof - and we all know how that turned out
"In order to accelerate the overall development plan, in parallel with conducting the Phase 2 trials Neuren is executing the additional development work
required to be ready for Phase 3 development. This includes non-clinical toxicity studies to support longer clinical trials and commercial use of the product as well as optimisation of the drug product and drug substance manufacturing arrangements."
- Forums
- ASX - By Stock
- Ann: Q4 2023 quarterly activity report
Fantastic reading, as expected.I have confidence in their...
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$19.43 |
Change
0.090(0.47%) |
Mkt cap ! $2.461B |
Open | High | Low | Value | Volume |
$19.60 | $19.65 | $19.00 | $3.670M | 189.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 90 | $19.43 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.44 | 67 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10 | 19.420 |
3 | 155 | 19.410 |
3 | 343 | 19.400 |
2 | 216 | 19.390 |
4 | 262 | 19.380 |
Price($) | Vol. | No. |
---|---|---|
19.440 | 168 | 3 |
19.450 | 274 | 6 |
19.460 | 200 | 2 |
19.470 | 252 | 4 |
19.480 | 856 | 6 |
Last trade - 12.08pm 06/06/2024 (20 minute delay) ? |
|
|||||
Last
$19.37 |
  |
Change
0.090 ( 0.34 %) |
|||
Open | High | Low | Volume | ||
$19.58 | $19.62 | $19.00 | 75150 | ||
Last updated 12.28pm 06/06/2024 ? |
Featured News
NEU (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
Previous Video
Next Video
SPONSORED BY The Market Online